Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption – an individual-level prescription database study

This publication has 16 references indexed in Scilit:

• Why do sales of lipid-lowering drugs vary between counties in Norway?
  Scandinavian Journal of Primary Health Care, 2006
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
  The Lancet, 2005
• Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997–2003
  British Journal of Clinical Pharmacology, 2005
• Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based study: the Troms study 2001
  European Journal of Clinical Pharmacology, 2004
• Undertreatment and overtreatment with statins: the Oslo Health Study 2000–2001
  Journal of Internal Medicine, 2004
• Quality of lipid‐lowering therapy in patients with ischaemic heart disease: a register‐based study in 3477 patients
  Journal of Internal Medicine, 2004
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated?
  British Journal of Clinical Pharmacology, 2002
• Use of lipid‐lowering drugs during 1991–98 in Northern Jutland, Denmark
  British Journal of Clinical Pharmacology, 2001
• Changes in the utilisation of lipid-lowering drugs over a 6-year period (1993-1998) in a Danish population.
  European Journal of Clinical Pharmacology, 2001